在标准化输液度下,ICU Y-site的兼容性:方法分层合成和实践图表
Gemma Garreta Fontelles1, Helena Padilla Castaño2, Marta Lopez Lopez-Cepero2
1Pharmacy Department, Hospital Universitario Son Espases, Palma, Spain gemma.garreta@ssib.es.
关键护理药物兼容性往往是不确定的. 这项研究创建了一个ICU特定的图表,发现不到一半的Y位点药物配对是兼容的,许多缺乏度匹配数据.
科学领域:
- 药理学 药理学是指药理学的学科.
- 密集护理医学 密集护理医学
- 药物兼容性研究 药物兼容性研究
背景情况:
- 严重病情严重的成年人通常需要多次静脉注射,需要Y位共注射.
- 现有的兼容性数据可能不反映当前重症监护室 (ICU) 关于药物度和方法的实践.
- 这种差异可能会因为潜在的虚假安慰而危及患者的安全.
研究的目的:
- 开发一个特定于ICU的Y-site药物兼容性图表,使用标准化度.
- 识别与ICU环境相关的兼容,有条件,不兼容和缺乏数据的药物对.
主要方法:
- 在Prisma原则的指导下进行了系统审查 (1970-2025年).
- 仪器终点 (例如,pH,度测量,HPLC) 优先于视觉检查.
- 药物对被映射到第三级成人ICU表单中,识别ICU标准化药物.
主要成果:
- 在4465种药物对中,43.94%是兼容的,2.53%是有条件的,8.24%是不兼容的,45.29%没有合格的证据.
- 高风险药物类别包括脂质乳液,极端pH剂,素和盐.
- 阿米奥达龙的兼容性通常依赖于度,突出了非标准化度的问题.
结论:
- 在标准化ICU度下,不到一半的潜在Y位药物配对是兼容的,数据中存在显著的差距.
- 使用精确度和稀释剂的保守框架减轻了风险,并确定了关键证据缺口.
- 将这种兼容性图表集成到电子处方系统中可以提高安全性并优化药物管理.
更多相关视频
11:15Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
06:20Contrast-Enhanced Subharmonic Aided Pressure Estimation SHAPE Using Ultrasound Imaging with a Focus on Identifying Portal Hypertension
Published on: December 5, 2020
相关概念视频
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
One-Compartment Model: IV Infusion
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Expressing Solution Concentration
Concentrations may be quantitatively assessed using a wide variety of measurement units, each convenient for particular applications. Molarity (M) is a useful concentration unit for many applications in chemistry.
Dosage Interval and Administration Route: Determination Methods
Two-Compartment Open Model: IV Infusion
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
